Collaboration and cooperation are key when taking research to market, writes Rowan Gilmore. [ + ]

A new environment for pharmaceutical companies is on the horizon and it will be the fittest who survive, predicts Ian Nisbet. [ + ]

The life sciences can learn from the IT revolution, Prashant Tyagi explains. [ + ]

With technology advancing so rapidly in many potential commercial areas of life science, patent attorneys, intellectual property (IP) and commercial lawyers, and lawmakers will face a number of challenges over the next 10 years, says Trevor Davies. [ + ]

Advocates and opponents of stem cell research across Australia are gearing up for the reignition of the debate that polarised Australia's state and federal governments in 2002. [ + ]

A change is needed in the way science is taught, argues Kathy Takayama. [ + ]

Over the next decade two powerful forces, economics and technology, will reshape teaching hospital laboratories, writes Ross Vining. [ + ]

Australians lead the way in vaccine research for malaria and other infectious diseases, writes Michael Good. [ + ]

Miranda Grounds spoke with Susan Williamson about how art is helping to drive things forward in science. [ + ]

Ethics need to change radically to keep up with technology, write Julian Savulescu and Bennett Foddy. [ + ]

Bob Williamson calls on long experience to express hopes for the future. [ + ]

Prevention and prevention strategies form the basis of a coordinated path for the future of child healthcare, writes Fiona Stanley. [ + ]

Simon Easteal and Pythia Demonsthenes step back from 2050 to brief us on a century of healthcare. [ + ]

The Lorne Proteomics Symposium is geared towards assessing practical solutions for the technology. [ + ]

This year's Lorne Protein conference was preceded by a one-day workshop-style event, the Biomolecular Dynamics and Interactions Symposium, at the new Bio21 Molecular Science and Biotechnology Institute in Melbourne's Parkville. [ + ]